This article is more than 5 years old. Information may no longer be current.

VIDEO: Surgeon reports 2-year data on the COMPASS trial

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

MILAN — At the OSN Italy meeting, E. Randy Craven, MD, discusses minimally invasive glaucoma surgery focusing on the 2-year results of the COMPASS trial on the CyPass micro-stent from Transcend Medical, as well as methods of sustained IOP reduction with an implantable drug delivery system.